miRoncol Health

Profile

miRoncol Health is a Canadian precision health company developing a microRNA based, real-time multi-cancer early risk assessment. Using microRNA biomarkers and AI-based pattern recognition, miCheckup identifies molecular signatures associated with more than a dozen common solid tumours. The test provides an accessible, affordable pre-screen that complements established screening programs and supports physician-guided follow-up. miRoncol is seeking clinical, laboratory and commercialization partners to expand access to proactive cancer risk assessment that leads to early detection internationally.

miRoncol Health A miracle in oncology powered by miRNA logo

Website

mironcol.com

Contact


Event details

Date: September 8 - 10, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

12 in total